Skip to content

Author

A. Tantiworawit

We have 2 of 219 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Prediction model for survival outcome in patients with acute myeloid leukemia: a multicenter prospective cohort study from Thai Acute Leukemia Working Group

Introduction Despite the development of advanced therapeutic approaches in the last two decades, acute myeloid leukemia (AML) has a poor prognosis, especially in older patients. The main causes of death are refractory/relapsed disease, fatal bleeding, or serious infection. A model to predict survival in patients with A...

Pirun Saelue, J. Julamanee, A. Tantiworawit et al. · 0 citations
Open access Sep 2026

Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients

Donor-derived anti-CD19 chimeric antigen receptor T-cell (CAR T-cell) therapy has emerged as one of the most promising treatments for relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). In this retrospective study, we evaluated the safety and efficacy of donor-derived anti-CD19 CAR T cells manufactur...

Supavich Tannumsaeng, U. Anurathapan, Arpatsorn Sermcheep et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.